InflaRx N.V. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was EUR 0.036037 million. Net loss was EUR 9.66 million compared to EUR 11.08 million a year ago.

Basic loss per share from continuing operations was EUR 0.17 compared to EUR 0.25 a year ago. Diluted loss per share from continuing operations was EUR 0.17 compared to EUR 0.25 a year ago.